Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24968299 | 0.79 | CYP2C19 (0.36) | CYP2C19 | |
| SCHEMBL23713628 | 0.77 | CYP2C19 (0.35) | CYP2C19 | |
| SCHEMBL13588603 | 0.72 | CYP2C19 (0.41) | CYP2C19 | |
| SCHEMBL31046808 | 0.65 | CYP2C19 (0.45) | CYP2C19 | |
| SCHEMBL27207751 | 0.61 | CYP2C19 (0.40) | CYP2C19 | |
| SCHEMBL23702675 | 0.61 | CES2 (0.30) | — | |
| SCHEMBL26189394 | 0.61 | CYP2C19 (0.40) | CYP2C19 | |
| 1,10-Dihydronootkatone SCHEMBL23954040 | 0.58 | CYP2C19 (0.44) | CYP2C19 | |
| 1,10-Dihydronootkatone SCHEMBL20608607 | 0.58 | CYP2C19 (0.44) | CYP2C19 | |
| SCHEMBL26189395 | 0.57 | CYP2C19 (0.35) | CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230139806-A1 | SELENIDE DERIVATIVES OF FRAGRANCE COMPOUNDS | SYMRISE AG (DE) | 2023-05-04 | — | — | US | disclosed |
| EP-4097081-A1 | SELENIDE DERIVATIVES OF FRAGRANCE COMPOUNDS | Symrise AG (DE) | 2022-12-07 | — | — | EP | disclosed |
| CN-115052859-A | Selenide derivatives of fragrance compounds | 西姆莱斯股份公司 | 2022-09-13 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230139806-A1 | SELENIDE DERIVATIVES OF FRAGRANCE COMPOUNDS | SELENOI, FASN, EBP | CYP2C19 751/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.